alexa Is There A Need For An Intellectual Property (IP) Policy In South Africa?
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Pharmaceutical Regulatory Affairs
September 08-10, 2014 DoubleTree by Hilton Hotel Raleigh-Brownstone-University, USA

Makhapa Makhafola
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.016
Abstract
South Africa does not have a national IP policy as a result the government departments that deal directly or indirectly with IP approach the system differently. The country?s patent laws are costing the health sector dearly. The health organisations and government are paying heavily to provide life-saving drugs and medical devises to those who can?t afford them. In the absence of the IP policy the government has implemented other intervention strategies that will help with the development of some of the drugs and medical devices locally. One of these strategies is the nanotechnology strategy established through the Department of Science and Technology (DST) to address critical socio-economic challenges facing the country. The DST/ Mintek Nanotechnology Innovation Centre (NIC) was established as one of the major implementing agencies of the national nanotechnology strategy to focus primarily on the social cluster (health and water). The motivation to focus on the health sector is that there is lack of regulations in pricing of the drugs and medical devices. ?Other developing nation like Brazil, India and Argentina have taken steps to build safeguards to protect public health South Africa hasn?t done the same extent?. The World Health Organization has shown that 67% of deaths in South Africa are due to communicable diseases and the cost of drugs and medical devices is controlled by pharmaceutical industries. This paper addresses whether there is a need to have an IP policy in SA and how has the government intervention strategies (like the NIC) progressed in the absence of the IP policy and also the impasse between the government and pharmaceutical industries with regard to the draft IP policy.
Biography
Makhapa Makhafola is currently the General Manager: Research & Development at Mintek. He worked as Lecturer in Analytical Chemistry at Tshwane University of Technology and University of Venda. In 2004, was appointed Director: Quality Assurance at Walter Sisulu University). He was the Director: Quality Assurance at the University of Venda until he joined University of Kwa-Zulu Natal as the Director Quality Promotion & Assurance in July 2010, part of his responsibility was to lead the World University Rankings project. He served as member of various boards and committees. He is currently the Chairperson of DST/MINTEK NIC Steering Committee. He did the post-doctoral training at Indiana University and presented his research work in more than 23 international conferences and published in credible journals. He is currently serving on various government initiatives like the Green Technology Task Team and Monitoring, Evaluation and Indicators Project Team
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords